Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA Clinical Trial Registry Will Be Launched Oct. 1

This article was originally published in The Pink Sheet Daily

Executive Summary

Clinicalstudyresults.org will include results of all controlled “hypothesis testing” clinical trials completed since October 2002 for PhRMA member companies’ marketed products. Postings will include a drug’s label, a bibliography of published studies, and summaries of unpublished studies.

You may also be interested in...



Sen. Gregg To Propose Clinical Trial Database Act

Act would mandate registry of clinical trials performed for all U.S. marketed products only; competing bill calls for database of all drugs, biologics and devices.

Sen. Gregg To Propose Clinical Trial Database Act

Act would mandate registry of clinical trials performed for all U.S. marketed products only; competing bill calls for database of all drugs, biologics and devices.

Clinical Trial Sponsors Urged To Post Study Design Details Ahead Of Results

Vermont Assistant Attorney General Brill says disclosure of clinical trial results on a central registry and posting of a study's design and endpoints before the results would suggest "true disclosure," not off-label marketing.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060770

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel